Skip to main content
. Author manuscript; available in PMC: 2017 Oct 1.
Published in final edited form as: Drug Deliv Transl Res. 2016 Oct;6(5):551–564. doi: 10.1007/s13346-016-0309-8

Table 3.

Prior vaginal product usage from a Check All That Apply (CATA) question, so column totals may exceed 100%. Numbers in right two columns indicate the % of participants (n=99 for test 1 and n=94 for test 2).

Vaginal products used Test 1 Test 2
Vaginal contraceptive products such as NuvaRing® 10.1 8.5
Spermicidal gels and films 3.0 2.1
Yeast infection medicines such as Vagisil® and Monistat 23.3 23.4
Douche 6.1 3.2
Menstruation products such as tampons 75.8 77.7
Lubrication products such as KY® gels, liquibeads and Vitamin-E suppositories 27.3 36.2